Genocea Biosciences Inc - ESG Rating & Company Profile powered by AI
The webpage of Genocea Biosciences Inc is assembled by All Street Sevva using advanced artificial intelligence. Check the end of this page for potential risks for Genocea Biosciences Inc based on sector, location and marketcap. This webpage is a free Sustainability analysis for Genocea Biosciences Inc.
Genocea Biosciences Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 0.0; made up of an environmental score of 0.0, social score of 0.0 and governance score of 0.0.
0.0
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1967 | Hospira Inc | 0.3 | Low |
| 1967 | PRA Health Sciences Inc | 0.3 | Low |
| 1970 | Genocea Biosciences Inc | 0.0 | Low |
| 1970 | CSPC Innovation Pharmaceutical Co Ltd | 0.0 | Low |
| 1970 | CTC Bio Inc | 0.0 | Low |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Genocea Biosciences Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Genocea Biosciences Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Genocea Biosciences Inc report the average age of the workforce?
Sign up for free to unlockDoes Genocea Biosciences Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Genocea Biosciences Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Genocea Biosciences Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Genocea Biosciences Inc offer flexible work?
Sign up for free to unlockDoes Genocea Biosciences Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Genocea Biosciences Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Genocea Biosciences Inc conduct supply chain audits?
Sign up for free to unlockDoes Genocea Biosciences Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Genocea Biosciences Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Genocea Biosciences Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Genocea Biosciences Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Genocea Biosciences Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Genocea Biosciences Inc disclose water use targets?
Sign up for free to unlockDoes Genocea Biosciences Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Genocea Biosciences Inc have a product recall in the last two years?
Sign up for free to unlockDoes Genocea Biosciences Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Genocea Biosciences Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Genocea Biosciences Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Genocea Biosciences Inc disclose parental leave metrics?
Sign up for free to unlockDoes Genocea Biosciences Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Genocea Biosciences Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Genocea Biosciences Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Genocea Biosciences Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Genocea Biosciences Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Genocea Biosciences Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Genocea Biosciences Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Genocea Biosciences Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Genocea Biosciences Inc disclose its waste policy?
Sign up for free to unlockDoes Genocea Biosciences Inc report according to TCFD requirements?
Sign up for free to unlockDoes Genocea Biosciences Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Genocea Biosciences Inc disclose energy use targets?
Sign up for free to unlockDoes Genocea Biosciences Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Genocea Biosciences Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Genocea Biosciences Inc
These potential risks are based on the size, segment and geographies of the company.
Genocea Biosciences, Inc., a biopharmaceutical company, discovers and develops novel cancer immunotherapies. The company uses its proprietary discovery platform, ATLAS, which profiles each patient's CD4+ and CD8+ T cell immune responses to every target or antigen identified by next-generation sequencing of that patient's tumor. Its products include GEN-011, an adoptive T cell therapy, which is in Phase 1/2a clinical trials for the treatment of solid tumors; and GEN-009, a neoantigen vaccine candidate, which is in Phase 1/2a clinical trials that delivers adjuvanted synthetic long peptides spanning ATLAS-identified anti-tumor neoantigens. The company was incorporated in 2006 and is based in Cambridge, Massachusetts. On July 5, 2022, Genocea Biosciences, Inc. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Massachusetts.